Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Lymphoma, Non-Hodgkin

cetylpyridinium chloride anhydrous has been researched along with Lymphoma, Non-Hodgkin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lybeert, M; Mols, F; Nijziel, MR; Oerlemans, S; van de Poll-Franse, LV1
Davis, B; George, SL; Pratt, CB; Schwartzbaum, JA1

Reviews

1 review(s) available for cetylpyridinium chloride anhydrous and Lymphoma, Non-Hodgkin

ArticleYear
The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.
    Annals of hematology, 2011, Volume: 90, Issue:9

    Topics: Algorithms; Female; Health; Health Status Indicators; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Quality of Life; Socioeconomic Factors; Survivors; Treatment Outcome

2011

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Lymphoma, Non-Hodgkin

ArticleYear
An exploratory study of environmental and medical factors potentially related to childhood cancer.
    Medical and pediatric oncology, 1991, Volume: 19, Issue:2

    Topics: Breast Feeding; Child; Environment; Female; Health; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Neoplasms; Neuroblastoma; Odds Ratio; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rhabdomyosarcoma; Sarcoma, Ewing; Smoking; Tennessee; Wilms Tumor

1991